MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Tagged Understanding Science

biomarker

Understanding Science: What is a Biomarker?

MStranslate
June 8, 2022
Understanding Science
We often hear the term 'biomarker' used in medical research, but what does it mean? In the video below, our co-founder and chief science...
fake news

FAKE NEWS ALERT: COVID Vaccines & MS

MStranslate
June 2, 2021
Research, Understanding Science
4 Comments
If you have been following MStranslate for a while, you will know that one of my pet hates is the poor reporting of multiple sclerosis research...

Predicting Progression: Science Fiction or Reality?

MStranslate
April 9, 2019
Understanding Science
Yesterday, we posed a question on our Facebook page and asked people to use reactions to indicate how they would vote… Some people may be...
b cells

B Cells & Their Role in Multiple Sclerosis

MStranslate
January 4, 2019
B Cells, Basic Sciences, Research, Understanding Science
1 Comment
B cells…we hear about them all the time in relation to multiple sclerosis, but what actually are they? Having done a poll on our Facebook page...
Dr Travis Stiles

Developing Next Gen Multiple Sclerosis Therapies: Part 5

MStranslate
April 26, 2018
Dr Travis Stiles, Research, Treatments, Understanding Science
5 Comments
The following is part of a MStranslate exclusive series which highlights the struggles and obstacles in developing the next generation of therapies...
Dr Travis Stiles

Developing Next Gen Multiple Sclerosis Therapies: Part 4

MStranslate
April 10, 2018
Dr Travis Stiles, Research, Treatments, Understanding Science
The following is part of a MStranslate exclusive series which highlights the struggles and obstacles in developing the next generation of therapies...
Dr Travis Stiles

Developing Next Gen Multiple Sclerosis Therapies: Part 3

MStranslate
March 27, 2018
Dr Travis Stiles, Research, Treatments, Understanding Science
1 Comment
The following is part of a MStranslate exclusive series which highlights the struggles and obstacles in developing the next generation of therapies...
Dr Travis Stiles

Developing Next Gen Multiple Sclerosis Therapies: Part 2

MStranslate
March 20, 2018
Dr Travis Stiles, Research, Treatments, Understanding Science
The following is part two of an MStranslate exclusive series which highlights the struggles and obstacles in developing the next generation of...
Dr Travis Stiles

Developing Next Gen Multiple Sclerosis Therapies: Part 1

MStranslate
March 13, 2018
Dr Travis Stiles, Research, Treatments, Understanding Science
1 Comment
The following is part of an MStranslate exclusive series which highlights the struggles and obstacles in developing the next generation of therapies...
animal models

Animal Models of Multiple Sclerosis – Are They Useful?

MStranslate
October 3, 2017
Research, Understanding Science
Animal models of multiple sclerosis are not perfect.  I think that is an important first point to make.  As we still don’t know what causes...
  1. 1
  2. 2
  3. 3

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.